Interaction of mitochondria and lysosomes key in Parkinson’s disease
Northwestern Medicine scientists have identified the consequences of contact between the mitochondria and the lysosome in the axons and synapses …
Home ยป
Northwestern Medicine scientists have identified the consequences of contact between the mitochondria and the lysosome in the axons and synapses …
Grafting neurons grown from monkeys’ own cells into their brains relieved the debilitating movement and depression symptoms associated with Parkinson’s …
A hallmark of Parkinson’s disease is the degeneration of a group of dopaminergic neurons in the brain, which play key …
Within our body and on our skin, trillions of bacteria and viruses exist as part of complex ecosystems called microbiomes. …
A multi-institutional research team has demonstrated that hyper-activation and weakened functional connectivity of the subthalamic nucleus (STN) are neural markers …
Parkinson’s disease is most commonly treated with levodopa, a drug which alleviates the slowing of bodily movements, called bradykinesia, found …
While movement problems are the main symptoms of Parkinson’s disease, people with the disease often have non-motor symptoms such as …
Bipolar disorder patients are more than THREE TIMES more likely to get Parkinson’s, major review finds Those with bipolar faced …
Drug that treats an enlarged prostate may ‘slow disability’ in Parkinson’s sufferers by ‘blocking cell death in the brain’ Drug …
A traumatic brain injury is often easily suspected and can be confirmed and treated if necessary following an injury using …
Hope for Parkinson’s as scientists spot signs of the cruel disorder in the brain YEARS before patients show any of …
Having a parent with Alzheimer’s disease has been known to raise a person’s risk of developing the disease, but new …
Parkinson’s disease affects around half a million people in the United States, and the number is only expected to rise …
The federal Food and Drug Administration has approved a new, scalpel-free treatment for tremor in patients with medication-resistant Parkinson’s disease. …